Becton, Dickinson and (BDX) ROA: History & Chart

Becton, Dickinson and Company (BDX)BDXBecton, Dickinson and Company

About Becton, Dickinson and Company

Operating globally, Becton, Dickinson and Company (BD) is a prominent enterprise focused on the development, manufacturing, and distribution of a broad spectrum of medical technology. This includes essential medical supplies, sophisticated devices, advanced laboratory equipment, and critical diagnostic products. Its extensive customer base comprises healthcare providers, clinical institutions, medical researchers, pharmaceutical firms, and the general public around the world. The BD Medical division delivers a comprehensive suite of products primarily focused on medication management and drug delivery. This encompasses a variety of intravenous (IV) access solutions, such as peripheral and advanced catheters, central lines, acute dialysis catheters, and related vascular care items including needle-free connectors and closed-system drug transfer devices. It also provides essential injection equipment like hypodermic syringes, needles, anesthesia trays, enteral syringes, and sharps disposal systems. Additionally, this segment develops integrated systems for IV medication and infusion therapy, medication compounding workflow, automated dispensing, and supply chain optimization. Specialized products for diabetes management, including pen needles, along with prefillable drug delivery systems, are also key offerings. BD Life Sciences focuses on diagnostic and research tools, offering products for specimen and blood collection. This segment supplies automated systems for culturing blood and tuberculosis, molecular testing, microorganism identification, and drug susceptibility analysis. It also provides liquid-based cytology systems, rapid diagnostic assays, microbiology laboratory automation, and plated media. Furthermore, it offers advanced solutions for cell analysis, including fluorescence-activated cell sorters and analyzers, antibodies, kits, and reagent systems. These are crucial for single-cell gene expression analysis, as well as for clinical oncology, immunological, and transplantation diagnostics and monitoring. Finally, the BD Interventional segment delivers specialized products for surgical and interventional procedures. Its portfolio includes solutions for hernia and soft tissue repair, biological and bioresorbable grafts, and biosurgery, alongside other surgical products. This segment also addresses surgical infection prevention, provides a range of surgical and laparoscopic instrumentation, offers peripheral intervention products, and supplies urology and critical care devices. Established in 1897, the company maintains its headquarters in Franklin Lakes, New Jersey.

Franklin Lakes, NJ

72,000 employees

www.bd.com

Healthcare / Medical - Instruments & Supplies

Sector: Healthcare
Industry: Medical - Instruments & Supplies
CEO: Thomas E. Polen Jr.

View full financials

BDX Return on Assets (ROA) Metrics

RETURN ON ASSETS (ROA)

2.24%

RETURN ON ASSETS (ROA) AVG TTM

3.00%

RETURN ON ASSETS (ROA) AVG 3Y

3.04%

RETURN ON ASSETS (ROA) AVG 5Y

2.95%

RETURN ON ASSETS (ROA) AVG 10Y

2.72%

RETURN ON ASSETS (ROA) AVG 15Y

5.39%

RETURN ON ASSETS (ROA) AVG 20Y

7.09%

CURRENT VS TTM AVG

-25.46%

CURRENT VS 3Y AVG

-26.44%

CURRENT VS 5Y AVG

-23.98%

CURRENT VS 10Y AVG

-17.76%

CURRENT VS 15Y AVG

-58.45%

CURRENT VS 20Y AVG

-68.39%

SECTOR MEDIAN · HEALTHCARE

4.93%

median of 79 covered companies

CURRENT VS SECTOR MEDIAN

-54.56%

vs the sector median at left

NAME	MARKET CAP	RETURN ON ASSETS (ROA)	TTM	3Y	5Y
Becton, Dickinson and Company (BDX)	$60.26B	2.24%	3.00%	3.04%	2.95%
Cencora, Inc. (COR)vs ›	$62.18B	3.12%	2.14%	2.52%	0.85%
Cardinal Health, Inc. (CAH)vs ›	$54.46B	2.75%	2.42%	0.86%	-0.71%
Boston Scientific Corporation (BSX)vs ›	$68.46B	8.01%	5.66%	4.50%	3.49%
Regeneron Pharmaceuticals, Inc. (REGN)vs ›	$71.62B	10.82%	11.40%	12.40%	16.97%
Edwards Lifesciences Corporation (EW)vs ›	$48.18B	8.20%	19.91%	18.29%	17.04%
Humana Inc. (HUM)vs ›	$46.67B	2.04%	2.52%	4.20%	5.49%
IDEXX Laboratories, Inc. (IDXX)vs ›	$44.93B	32.35%	29.29%	27.30%	27.52%
Cigna Corporation (CI)vs ›	$79.64B	4.10%	2.99%	3.50%	3.82%
IQVIA Holdings Inc. (IQV)vs ›	$40.61B	4.60%	4.82%	4.76%	4.01%

NAME

MARKET CAP

RETURN ON ASSETS (ROA)

TTM

Becton, Dickinson and Company (BDX)

$60.26B

2.24%

3.00%

3.04%

2.95%

Cencora, Inc. (COR)vs ›

$62.18B

3.12%

2.14%

2.52%

0.85%

Cardinal Health, Inc. (CAH)vs ›

$54.46B

2.75%

2.42%

0.86%

-0.71%

Boston Scientific Corporation (BSX)vs ›

$68.46B

8.01%

5.66%

4.50%

3.49%

Regeneron Pharmaceuticals, Inc. (REGN)vs ›

$71.62B

10.82%

11.40%

12.40%

16.97%

Edwards Lifesciences Corporation (EW)vs ›

$48.18B

8.20%

19.91%

18.29%

17.04%

Humana Inc. (HUM)vs ›

$46.67B

2.04%

2.52%

4.20%

5.49%

IDEXX Laboratories, Inc. (IDXX)vs ›

$44.93B

32.35%

29.29%

27.30%

27.52%

Cigna Corporation (CI)vs ›

$79.64B

4.10%

2.99%

3.50%

3.82%

IQVIA Holdings Inc. (IQV)vs ›

$40.61B

4.60%

4.82%

4.76%

4.01%

Return on Assets (ROA) FAQ

What is the return on assets (ROA) for Becton, Dickinson and Company (BDX)?

The return on assets (ROA) for BDX stock is 2.24%.

Is Becton, Dickinson and Company's return on assets (ROA) high or low?

The return on assets (ROA) of 2.24% is 24% below its 5-year average of 2.95%, near the low end of its 5-year range (1.62%–3.88%).

What is the TTM average return on assets (ROA) for Becton, Dickinson and Company (BDX)?

The TTM average return on assets (ROA) for BDX stock is 3.00%.

What is the 3Y average return on assets (ROA) for Becton, Dickinson and Company (BDX)?

The 3Y average return on assets (ROA) for BDX stock is 3.04%.

What is the 5Y average return on assets (ROA) for Becton, Dickinson and Company (BDX)?

The 5Y average return on assets (ROA) for BDX stock is 2.95%.

What is the 10Y average return on assets (ROA) for Becton, Dickinson and Company (BDX)?

The 10Y average return on assets (ROA) for BDX stock is 2.72%.

What is the 15Y average return on assets (ROA) for Becton, Dickinson and Company (BDX)?

The 15Y average return on assets (ROA) for BDX stock is 5.39%.

What is the 20Y average return on assets (ROA) for Becton, Dickinson and Company (BDX)?

The 20Y average return on assets (ROA) for BDX stock is 7.09%.

DATE	RETURN ON ASSETS (ROA)
2025-09-30	3.03%
2024-09-30	2.98%
2023-09-30	2.81%
2022-09-30	3.36%
2021-09-30	3.88%
2020-09-30	1.62%
2019-09-30	2.38%
2018-09-30	0.58%
2017-09-30	2.92%
2016-09-30	3.81%
2015-09-30	2.59%
2014-09-30	9.52%
2013-09-30	10.64%
2012-09-30	10.30%
2011-09-30	12.19%
2010-09-30	13.65%
2009-09-30	13.24%
2008-09-30	14.24%
2007-09-30	12.14%
2006-09-30	11.02%
2005-09-30	11.90%
2004-09-30	8.13%
2003-09-30	9.82%
2002-09-30	9.52%
2001-09-30	8.36%
2000-09-30	8.72%
1999-09-30	6.21%
1998-09-30	6.15%
1997-09-30	9.74%
1996-09-30	9.81%

DATE

RETURN ON ASSETS (ROA)

2025-09-30

3.03%

2024-09-30

2.98%

2023-09-30

2.81%

2022-09-30

3.36%

2021-09-30

3.88%

2020-09-30

1.62%

2019-09-30

2.38%

2018-09-30

0.58%

2017-09-30

2.92%

2016-09-30

3.81%

2015-09-30

2.59%

2014-09-30

9.52%

2013-09-30

10.64%

2012-09-30

10.30%

2011-09-30

12.19%

2010-09-30

13.65%

2009-09-30

13.24%

2008-09-30

14.24%

2007-09-30

12.14%

2006-09-30

11.02%

2005-09-30

11.90%

2004-09-30

8.13%

2003-09-30

9.82%

2002-09-30

9.52%

2001-09-30

8.36%

2000-09-30

8.72%

1999-09-30

6.21%

1998-09-30

6.15%

1997-09-30

9.74%

1996-09-30

9.81%

Return on Assets (ROA): 2.24%

BDX Return on Assets (ROA) Chart

BDX Average Return on Assets (ROA) Chart

BDX Current vs Average Return on Assets (ROA) Chart

BDX Return on Assets (ROA) Metrics

BDX Competitors' Return on Assets (ROA)

Asset Efficiency

Return on Assets (ROA) Formula & Definition

Return on Assets (ROA) FAQ

BDX Return on Assets (ROA) History

Related Metrics